These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 401715)

  • 1. Trimonam and mental retardation.
    Huston I; Swett C; Cole JO
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):70-2. PubMed ID: 401715
    [No Abstract]   [Full Text] [Related]  

  • 2. Mental retardation. Behavior problems and psychotropic drugs.
    Rothman CB; Chusid E; Giannini MJ
    N Y State J Med; 1979 Apr; 79(5):709-15. PubMed ID: 286168
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies on Wy 4036 (lorazepam), a new tranquilizing agent].
    Schrappe O
    Arzneimittelforschung; 1971 Jul; 21(7):1079-82. PubMed ID: 4935399
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behavior problems in adults with mental retardation. Psychopharmaceuticals are used too often--pedagogical efforts would be better].
    Näslund I
    Lakartidningen; 2007 Apr 4-17; 104(14-15):1132-5. PubMed ID: 17472101
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychopharmacology in the mentally retarded and a few related issues.
    Gualtieri CT; Keppel JM
    Psychopharmacol Bull; 1985; 21(2):304-9. PubMed ID: 2860694
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of psychopharmaceutical agents in children].
    Minderaa RB; Intveld AN; Vink HJ
    Ned Tijdschr Geneeskd; 1989 Feb; 133(5):252-6. PubMed ID: 2927536
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychotropic medication efficacy graphs: an application of applied behavior analysis.
    Spirrison CL; Grosskopf LG
    Ment Retard; 1991 Jun; 29(3):139-47. PubMed ID: 1881344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study on the use of psychotropic medication in persons with mental retardation.
    Radouco-Thomas M; Bolduc M; Brisson A; Brassard P; Fortier L; Thivierge J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):879-83. PubMed ID: 15363610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of psychotropic medication among individuals with mental retardation].
    Baasland G; Engedal K
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1751-3. PubMed ID: 19756056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-electroencephalographic evaluation of the anti-epileptic action of a new series of benzodiazepine derivatives].
    Turner M; Fejerman N; Schugurensky E; Cordero Funes JR; Cantlon B; Aspinwall R; Lon JC
    Acta Neurol Latinoam; 1970; 16(1):97-109. PubMed ID: 5000695
    [No Abstract]   [Full Text] [Related]  

  • 12. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
    de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
    Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication and programming in controlling the behavior of mentally retarded individuals in community settings.
    Schalock RL; Foley JW; Toulouse A; Stark JA
    Am J Ment Defic; 1985 Mar; 89(5):503-9. PubMed ID: 2859807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.
    Holden B; Gitlesen JP
    Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic trials and EEG investigations with SCH-12,679 in behaviorally disturbed adolescents.
    Itil TM; Stock MJ; Duffy AD; Esquenazi A; Saleuty B; Han TH
    Curr Ther Res Clin Exp; 1972 Mar; 14(3):136-50. PubMed ID: 4622893
    [No Abstract]   [Full Text] [Related]  

  • 16. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental test using a new antidepressive (thiazenone, SQ 10496). A controlled study using imipramine and placebo].
    Azcárate C
    Rev Neuropsiquiatr; 1969 Sep; 32(3):194-211. PubMed ID: 4916507
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and prediction of psychotropic drug use in California developmental centers.
    Stone RK; Alvarez WF; Ellman G; Hom AC; White JF
    Am J Ment Retard; 1989 May; 93(6):627-32. PubMed ID: 2719845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practitioner review: Psychopharmacology in children and adolescents with mental retardation.
    Handen BL; Gilchrist R
    J Child Psychol Psychiatry; 2006 Sep; 47(9):871-82. PubMed ID: 16930381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of psychotropic drugs].
    Nieto D
    Bol Estud Med Biol; 1974; Suppl 1():309-17. PubMed ID: 4619018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.